PROTHENA CORP PLC

Insider buying spree: SCULLY WILLIAM P adds 100K Prothena shares, boosting his stake to 27% and signalling confidence in the company’s antibody pipeline.

Prothena insider buying shows confidence in its antibody pipeline—director SCULLY WILLIAM P’s recent purchase signals the stock may be undervalued and poised for a rebound.